Metallic Nanoparticles for Pharmaceutical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 198
Special Issue Editors
Interests: metal nanoparticles; cell biology, scaffolds and nanotechnology applied to cancer
Special Issues, Collections and Topics in MDPI journals
Interests: nanoparticles; magnetic nanoparticles; cancer therapy
Special Issue Information
Dear Colleagues,
Metallic Nanoparticles (MNPs) have emerged as a versatile and powerful tool in the field of pharmaceutical applications. Their unique physicochemical properties, including size, shape, surface charge, and functionalization potential, enable MNPs to interact with biological systems in ways that can be finely tuned for specific applications. From targeted drug delivery systems to diagnostic imaging and therapeutic agents, MNPs are at the forefront of cutting-edge biomedical research.
This Special Issue aims to highlight the latest advancements and applications of metallic nanoparticles in the pharmaceutical field. We welcome submissions that explore the synthesis, characterization, and functionalization of MNPs, as well as their applications in cancer therapy, drug delivery, antimicrobial treatments, inflammatory disease, and tissue engineering. The goal is to showcase the state-of-the-art research and to foster a deeper understanding of how MNPs can be harnessed for innovative pharmaceutical solutions.
We invite original research articles and extensive reviews that contribute to the growing body of knowledge on metallic nanoparticles for pharmaceutical applications.
Dr. Thalita Marcolan Valverde
Prof. Dr. Guilherme Mattos Jardim Costa
Dr. Alfredo Miranda de Góes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metal nanoparticles (MNPs)
- synthesis
- characterization
- biomedicine
- pharmaceutical applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
